Table 3 Duration of hospitalization and outcomes following hospitalization.
Characteristic, n (%) | Cluster 1 n = 41 | Cluster 2 n = 28 | p-value |
|---|---|---|---|
Length of stay, median [IQR] | |||
ICU (days) | 3.0 [2.0, 3.0] | 3 [2.0, 3.0] | 0.304 |
Hospital (days) | 3.0 [3.0, 4.0] | 3 [3.0, 4.0] | 0.572 |
Discharged to | |||
Home | 39 (100) | 27 (100) | > 0.9 |
Inpatient rehabilitation | 1 (2.4) | 0 (0) | > 0.9 |
Discharge medications | |||
Albuterol or Xopenex | 41 (100) | 28 (100) | > 0.9 |
Montelukast | 18 (44) | 17 (61) | 0.260 |
ICS | 25 (61) | 14 (50) | 0.512 |
ICS + LABA | 18 (44) | 11 (39) | 0.894 |
Oral corticosteroid burst | 30 (73) | 19 (68) | 0.836 |
Dexamethasone | 3 (10) | 2 (11) | |
Prednisolone | 15 (50) | 4 (21) | |
Prednisone | 12 (40) | 13 (72) | |
Daily oral corticosteroids | 25 (61) | 13 (46) | 0.344 |
Primary outcome within 1 year | n = 33 | n = 23 | |
Any medical visit for asthma exacerbation | 8 (24) | 12 (52) | 0.063 |
Multiple asthma exacerbations | 6 (18) | 7 (30) | 0.455 |
Secondary outcome within 1 year | |||
Number of exacerbations, median [IQR] | 0.0 [0.0, 0.0] | 0.0 [0.0, 2.0] | 0.095 |
Follow-up location | |||
Urgent care/emergency department | 8 (24) | 12 (52) | 0.063 |
Asthma/allergy clinic | 14 (42) | 16 (70) | 0.083 |
# Asthma/allergy clinic visits, median [IQR] | 0.0 [0.0, 2.0] | 1.0 [0.0, 3.0] | 0.133 |
Hospitalized, n (%) | 6 (18) | 7 (30) | 0.455 |
# Inpatient admissions, median [IQR] | |||
General ward | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | > 0.9 |
ICU | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.727 |
